Neoadjuvant phase II trial of chemo-radiotherapy (CRT) in patients with resectable (R) and borderline resectable (BR) pancreatic ductal adenocarcinoma (PDA)

Publication date: March 2018
Source:European Journal of Cancer, Volume 92, Supplement 2
Author(s): V. Damarla, D. Dobrosotskaya, F. Siddiqui, I. Wollner, M. Raoufi, J. Li, D. Kwon, G. Khan




http://ift.tt/2FCc4Ff